Circulating tumor DNA kinetics in recurrent/metastatic head & neck squamous cell cancer (R/M HNSCC) patients

被引：0
|
作者：
Taylor, K. [1 ]
Zou, J. [2 ]
Burgener, J. [2 ]
Zhao, E. [3 ]
Torti, D. [4 ]
Oliva, M. [1 ]
Spreafico, A. [1 ]
Hansen, A. R. [1 ]
Jang, R. [1 ]
McDade, S. S. [5 ]
Coyle, V. M. [5 ]
Lawler, M. [5 ]
Elimova, E. [1 ]
Bratman, S. V. [3 ]
Siu, L. L. [1 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Hlth Network, Dept Radiat Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Ontario Inst Canc Res, Translat Genom Lab, Toronto, ON, Canada
[5] Queens Univ Belfast, Patrick G Johnston Ctr Canc Res, Belfast, Antrim, North Ireland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1296
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
886P
引用
收藏
页码：S796 / S797
页数：2
相关论文
共 50 条
  • [1] Personalized circulating tumor DNA (ctDNA) analysis in patients with recurrent/metastatic head and neck squamous cell cancer (R/M HNSCC).
    Taylor, Kirsty
    Zou, Jinfeng
    Magalhaes Filho, Marcos Aurelio Fonseca
    Howarth, Karen
    Marsico, Giovanni
    Terrell, Samantha
    Jones, Gregory
    Knape, Charlene
    Forshew, Tim
    Oliva, Marc
    Spreafico, Anna
    Hansen, Aaron Richard
    McDade, Simon
    Coyle, Victoria M.
    Lawler, Mark
    Elimova, Elena
    Bratman, Scott Victor
    Siu, Lillian L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients
    Taylor, Kirsty
    Zou, Jinfeng
    Magalhaes, Marcos
    Oliva, Marc
    Spreafico, Anna
    Hansen, Aaron R.
    McDade, Simon S.
    Coyle, Vicky M.
    Lawler, Mark
    Elimova, Elena
    V. Bratman, Scott
    Siu, Lillian L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 188 : 29 - 38
  • [3] Time of referral of patients (pts) with recurrent/metastatic (r/m) head and neck squamous cell cancer (HNSCC) to medical oncology and survival.
    Siano, Marco
    Espeli, Vittoria
    Desax, Marie-Claire
    Broglie, Martina Anja
    Joerger, Markus
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC).
    Scheff, Nicole N.
    Nilsen, Marci Lee
    Li, Jinhong
    Harris, Alexandria L.
    Swartz, Andrew
    Hsieh, Ronan Wenhan
    Anderson, Jennifer Lynn
    Ferris, Robert L.
    Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Biomarkers and response to pembrolizumab (pembro) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
    Chow, Laura Quan Man
    Mehra, Ranee
    Haddad, Robert I.
    Mahipal, Amit
    Weiss, Jared
    Berger, Raanan
    Eder, Joseph Paul
    Burtness, Barbara
    Tahara, Makoto
    Keam, Bhumsuk
    Le, Dung T.
    Muro, Kei
    Geva, Ravit
    Chung, Hyun Cheol
    Lin, Chia-Chi
    Ayers, Mark
    Aurora-Garg, Deepti
    Lunceford, Jared K.
    Cheng, Jonathan D.
    Seiwert, Tanguy Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Fury, Matthew G.
    Sherman, Eric
    Ho, Alan
    Katabi, Nora
    Sima, Camelia
    Kelly, Katherine W.
    Nwankwo, Oby
    Haque, Sofia
    Pfister, David G.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 121 - 128
  • [7] A phase II study of pemetrexed (P) plus gemcitabine (G) in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Pfister, D. G.
    Haque, S.
    Stambuk, H.
    Lisa, D. M.
    Shen, R.
    Carlson, D.
    Fury, M. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Matthew G. Fury
    Eric Sherman
    Alan Ho
    Nora Katabi
    Camelia Sima
    Katherine W. Kelly
    Oby Nwankwo
    Sofia Haque
    David G. Pfister
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 70 : 121 - 128
  • [9] Role of circulating tumour cells (CTCs) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)
    Baa, Annie Kanchan
    Sharma, Atul
    Bhaskar, Suman
    Biswas, Ahitagni
    Thakar, Alok
    Kumar, Rajeev
    Jayant, Sreeja
    Aland, Gourishankar
    D'Souza, Alain
    Jadhav, Vikas
    Bharde, Atul
    Khandare, Jayant
    Pramanik, Raja
    [J]. ECANCERMEDICALSCIENCE, 2023, 17
  • [10] A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
    Dunn, Lara
    Ho, Alan Loh
    Eng, Juliana
    Michel, Loren S.
    Fetten, James Vincent
    Warner, Elizabeth
    Kriplani, Anuja
    Zhi, Wanqing Iris
    Ng, Kenneth K.
    Haque, Sofia
    Pfister, David G.
    Sherman, Eric Jeffrey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345